Skip to content
healthcare.dev

Rizatriptan

NDC 33342-087, Rizatriptan, tablet, film coated, from Macleods Pharmaceuticals Limited.

Product NDC
33342-087
Status
Listed
Labeler
Macleods Pharmaceuticals Limited
Dosage form
TABLET, FILM COATED
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA203147
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/33342-087 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • RIZATRIPTAN BENZOATE5 mg/1

Pharmacologic classes

Serotonin 1b Receptor Agonists [MoA]; Serotonin 1d Receptor Agonists [MoA]; Serotonin-1b and Serotonin-1d Receptor Agonist [EPC]

Package NDCNDC-11Package
33342-087-073334200870730 TABLET, FILM COATED in 1 CONTAINER (33342-087-07)
33342-087-123334200871210 BLISTER PACK in 1 CARTON (33342-087-12) / 10 TABLET, FILM COATED in 1 BLISTER PACK
33342-087-41333420087413 BLISTER PACK in 1 CARTON (33342-087-41) / 6 TABLET, FILM COATED in 1 BLISTER PACK (33342-087-02)
33342-087-45333420087452 BLISTER PACK in 1 CARTON (33342-087-45) / 6 TABLET, FILM COATED in 1 BLISTER PACK (33342-087-02)
33342-087-4633342008746200 TABLET, FILM COATED in 1 CONTAINER (33342-087-46)
33342-087-50333420087504 BLISTER PACK in 1 CARTON (33342-087-50) / 3 TABLET, FILM COATED in 1 BLISTER PACK (33342-087-52)
33342-087-72333420087726 BLISTER PACK in 1 CARTON (33342-087-72) / 3 TABLET, FILM COATED in 1 BLISTER PACK (33342-087-52)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/27bc2cfc-fefb-4b50-a0dc-6268c69b4902
  • NADAC price for package 33342008741

    GET /v1/drugs/nadac/33342008741
  • NADAC price for package 33342008745

    GET /v1/drugs/nadac/33342008745

Use it

Look up 33342-087 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/33342-087 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 33342-087. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.